Skip to main content

Table 1 Baseline data

From: Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial

Baseline data IG
N = 36
CG
N = 28
Age (mean) 47.3 43.8
Females 19 (53 %) 22 (79 %)*
Education (highest degree)
 Secondary school 15 (41.7 %) 16 (57.1 %)
 Academic degree 21 (58.3 %) 12 (42.9 %)
Disease course**
 CIS 0 2 (7.4 %)
 RRMS 22 (61.1 %) 20 (71.4)
 SPMS 9 (25 %) 4 (14.3 %)
 PPMS 0 2 (7.1 %)
 Other 3 (8.3 %) 0
Disease duration (mean) 9.1 years 9.5 years
Currently on Immunotherapy 18 (50 %) 11 (39.3 %)
PDDS (mean) 2.86 2.04
  1. IG intervention group, CG control group, CIS clinically isolated syndrome, RRMS relapsing remitting multiple sclerosis, SPMS secondary progressive multiple sclerosis, PPMS primary progressive multiple sclerosis, PDDS patient determined disease steps
  2. *Statistical significant difference (p = 0,039), **Missing data for two participants in the IG